I’rom Pharma Of Japan Rides On Booming Mall Clinic Business
This article was originally published in PharmAsia News
Executive Summary
Japanese major infusion drug maker Tokyo-based I'rom Pharmaceutical has opened mall clinics in Tokyo and Kyoto. A mall clinic is a healthcare facility conveniently located in shopping centers, where shoppers can get treatments ranging from dental care to comprehensive medical checkups. I'rom Medic exec. Tetsu Minami, said mall clinics have allowed physicians with certain specialties to provide high-level care and to focus on local area residents. They also allow for information exchange with hospital care workers, resulting in an improvement in healthcare. I'rom mall clinics vary on services offered, ranging from dental, ophthalmology, internal medicine, surgery, orthopedics, dermatology to medical examination centers. (Click here for more - Japanese language
You may also be interested in...
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.